Manufacturing

A dual-sourcing strategy ensures that the pursuit of environmental milestones does not compromise the security of the supply chain for essential medical treatments. As global healthcare systems face unprecedented demand, the pharmaceutical industry is increasingly pressured to harmonize life-saving

Ethiopia's strategy reflects a broader continental trend toward health security, where local production is viewed as the only viable path to effective public health response. By 2030, the nation intends to transition from a major importer of medical goods to a self-reliant manufacturing powerhouse,

The global pharmaceutical landscape is navigating an era where ecological accountability has transitioned from a boardroom aspiration to a non-negotiable operational mandate for every stakeholder involved. Operating continuous utility systems to maintain cleanroom environments represents a

Faster-growing yeast cells in continuous culture produce enzymes with higher specific activity, suggesting that growth rate directly influences the quality of the final protein product. This discovery marks a pivotal shift in how bioengineers approach the metabolic trade-off between cellular growth

The current practice of requiring separate scientific assessments for the same product in fifty-four different countries discourages investment and increases the cost of doing business in Africa. This structural inefficiency has long kept the continent in a state of dependency, forcing it to import

Small-scale nanoparticles are uniquely capable of penetrating the dense architecture of biofilms to disrupt the quorum sensing communication that bacteria use to maintain their survival. This revelation comes at a time when the global medical community is facing a significant crossroads, as the